Health·3,527 stories
Researchers in Japan documented that long-clawed shrews physically expand their snouts in winter while the rest of their skull shrinks, a seasonal reversal of the known Dehnel's phenomenon, published
Nonprofit health system Bon Secours Mercy Health has collected more than $1.1 billion so far this year from its minority stake in Ensemble Health Partners, the medical billing company it spun off to i
The White House is claiming credit for a 3.1% annual drop in prescription drug prices — the steepest decline since 1963 — but STAT+ argues the reality behind the CPI headline is more complicated than
Top executives at major Massachusetts health care systems, including Mass General and Dana-Farber, received substantial pay increases in 2024 despite sector-wide financial strain and the collapse of S
Connecticut deployed its first state-funded mobile methadone vans this summer, backed by $4 million in opioid settlement funds, to bring medication treatment to rural and underserved areas where resid
Quantum cosmologist Sean Carroll and Johns Hopkins collaborators propose a cyclic cosmology in which the universe's quantum evolution is exactly periodic — every cycle identical — offering a mathemati
States have until Sept. 30 to decide whether to opt into a federal program giving Medicaid 'most-favored nation' drug prices — the lowest prices available to other major payers — per STAT's D.C. Diagn
Scientists in Japan have created female mice cloned from male cells by deleting the Y chromosome using CRISPR, enabling sexual reproduction between clones of a single male.
Researchers running a 60-year continuous study of yellow-bellied marmots in Colorado have raised over $100,000 through an OnlyFans account and a Solana-based memecoin after Trump administration scienc
A gut-bacteria byproduct called indole-3-propionic acid (IPA) reduced brain swelling and neuronal death in mice with traumatic brain injuries, with researchers tracing its protective effect to a speci
Amylyx Pharmaceuticals said its experimental drug cut serious low-blood-sugar events by 55% versus placebo in a Phase 3 trial of post-bariatric hypoglycemia patients, beating the 35% improvement the s
Enveda, a Boulder, Colorado biotech, released Phase 1 results Tuesday for an oral lac-phe mimic designed to suppress appetite and preserve lean muscle — targeting muscle loss and gastrointestinal side
Air traffic controllers will begin re-routing transatlantic flights through the Shanwick airspace in November using Google's AI contrail forecasts — the first airspace-wide, opt-out-mandatory test of
Public-sector employers are caught between surging health care costs and political resistance to tax hikes, forcing local leaders to raise property taxes and slash popular benefits like GLP-1 weight-l
A new theoretical study suggests the decades-long 'gallium anomaly' — a persistent ~20% shortfall in detected neutrinos — may stem from a flawed assumption in how experiments are modeled, rather than
A randomized trial from SWPS University and the Nencki Institute found that imagery-based psychotherapy significantly reduced fear of failure rooted in childhood criticism, with emotional and physiolo
A new study in Addiction finds kratom-related poison center cases in the U.S. increased more than 65-fold from 2010 to 2023, with severe medical outcomes rising from zero to 158 cases, and states that
University of Reading scientists studying three artisan British cheeses identified specific probiotic bacteria in each, with compounds linked to reduced inflammation, cholesterol regulation, and appet
Sanofi is laying off 229 workers in Massachusetts, all of whom came from Blueprint Medicines, the Cambridge biotech Sanofi acquired for $9.1 billion last July.
Eyepoint's Phase 3 trial for Duravyu, a less-frequent-injection treatment for a leading cause of age-related blindness, missed its primary goal, sending the biotech's stock plunging while rival Ocular
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.